in Newswire Published on October 13, 2020

Gilead, Bristol-Myers Squibb Facing Antitrust Class Action Over Alleged Anti-Competitive Grip on HIV Drug Market

KPH Healthcare Services, Inc. v. Gilead Sciences, Inc. et al.

Filed: October 6, 2020 § 3:20-cv-06961

A class action alleges Gilead Sciences and Bristol-Myers Squibb have for years conspired to restrain the U.S. market for HIV treatment drugs, allowing the companies to overcharge direct buyers.

Case Spotlight

Hair Relaxer Lawsuits

How Do I Join a Class Action Lawsuit?

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on October 13, 2020 — 3:05 PM

Corrado Rizzi

corrado@classaction.org

Corrado Rizzi is the Senior Managing Editor of ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.